Trial Profile
Randomized, Double-blind, Placebo-controlled Trial Investigating the Efficacy and Safety of Intravenous Neridronic Acid in Subjects With Complex Regional Pain Syndrome (CRPS)
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Neridronic acid (Primary)
- Indications Complex regional pain syndromes
- Focus Registrational; Therapeutic Use
- Sponsors Grunenthal
- 12 Aug 2019 Status changed from active, no longer recruiting to discontinued.
- 05 Jul 2019 Status changed from recruiting to active, no longer recruiting.
- 12 Jun 2018 According to a Grunenthal media release, the first patient has been enrolled in this trial.